Senescence in prostate cancer: is there sufficient evidence to move forward?
Minerva Urol Nephrol
.
2021 Aug;73(4):421-423.
doi: 10.23736/S2724-6051.21.04525-0.
Epub 2021 Jun 11.
Authors
Valerie Carpenter
1
2
,
Riccardo Autorino
3
,
David A Gewirtz
4
5
Affiliations
1
School of Medicine, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA -
[email protected]
.
2
Massey Cancer Center, Richmond, VA, USA -
[email protected]
.
3
Division of Urology, Department of Surgery, VCU Health, Richmond, VA, USA.
4
School of Medicine, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
5
Massey Cancer Center, Richmond, VA, USA.
PMID:
34114789
DOI:
10.23736/S2724-6051.21.04525-0
No abstract available
MeSH terms
Humans
Male
Prostatic Neoplasms*